ciprofloxacin has been researched along with Leukemia, Myeloid, Acute in 36 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A phase III randomized, controlled, clinical trial, open-label parallel-group with a 1:1 ratio, aimed to demonstrate the non-inferiority of oral fosfomycin versus oral ciprofloxacin for febrile neutropenia prevention in patients with acute leukemia (AL) or hematopoietic cell transplant (HSC) receptors." | 9.69 | FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients-efficacy and microbiologic safety. ( Amigo, ML; Bernal, T; Blanco, LS; Boluda, B; Burgués, JMB; Calabuig, ML; Casas, MC; de Miguel, MI; de Ugarriza, PL; Del Mar García-Saiz, M; Domínguez, JF; Hernández, SC; Huerta, AJG; Humala, K; Lavín-Alconero, L; Moreno, AF; Verdugo, AF; Zarzuela, MP, 2023) |
| "The purpose of this study was to identify risk factors and improve preventive strategies for febrile neutropenia (FEN) in children with leukemia who were receiving ciprofloxacin prophylaxis." | 8.31 | Identifying Risk Factors and Improving Preventive Strategies for Febrile Neutropenia in Children with Leukemia Receiving Ciprofloxacin Prophylaxis ( Alıcı, N; Kaya, Z; Kırkız, S; Koçak, Ü, 2023) |
| "The aim of the study was to describe the incidence and type of bacterial infections associated with the use of ciprofloxacin prophylaxis as single agent in pediatric patients with acute myeloid leukemia (AML)." | 7.85 | Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis. ( Al Omar, S; Al Qasem, W; Anabtawi, N; Rihani, R, 2017) |
| "In this retrospective study, we analyzed the clinical data and outcome of patients with AML who did or did not receive prophylactic ciprofloxacin 500 mg BD for neutropenic fever." | 7.83 | Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy. ( Foratyazdi, M; Ghadiany, M; Mehdizadeh, M; Mohammad Alizadeh, A; Rahimi, H; Rezvani, H; Zamani, N, 2016) |
| "Fifty consecutive episodes of neutropenia were studied in patients with AML who received prophylaxis with ciprofloxacin and these were compared with a historic control group of another 50 consecutive episodes of neutropenia in AML patients who did not receive antibiotic prophylaxis." | 7.69 | [Prophylaxis with ciprofloxacin in postchemotherapy neutropenia in acute myeloid leukemia]. ( Bueno, J; Juliá, A; López, A; Novo, A; Soler, JA, 1994) |
| "A phase III randomized, controlled, clinical trial, open-label parallel-group with a 1:1 ratio, aimed to demonstrate the non-inferiority of oral fosfomycin versus oral ciprofloxacin for febrile neutropenia prevention in patients with acute leukemia (AL) or hematopoietic cell transplant (HSC) receptors." | 5.69 | FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients-efficacy and microbiologic safety. ( Amigo, ML; Bernal, T; Blanco, LS; Boluda, B; Burgués, JMB; Calabuig, ML; Casas, MC; de Miguel, MI; de Ugarriza, PL; Del Mar García-Saiz, M; Domínguez, JF; Hernández, SC; Huerta, AJG; Humala, K; Lavín-Alconero, L; Moreno, AF; Verdugo, AF; Zarzuela, MP, 2023) |
| "The purpose of this study was to identify risk factors and improve preventive strategies for febrile neutropenia (FEN) in children with leukemia who were receiving ciprofloxacin prophylaxis." | 4.31 | Identifying Risk Factors and Improving Preventive Strategies for Febrile Neutropenia in Children with Leukemia Receiving Ciprofloxacin Prophylaxis ( Alıcı, N; Kaya, Z; Kırkız, S; Koçak, Ü, 2023) |
| "A retrospective chart review was completed comparing the use of prophylactic moxifloxacin to that of levofloxacin or ciprofloxacin during periods of prolonged neutropenia." | 3.85 | Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy. ( Przybylski, DJ; Reeves, DJ, 2017) |
| "The aim of the study was to describe the incidence and type of bacterial infections associated with the use of ciprofloxacin prophylaxis as single agent in pediatric patients with acute myeloid leukemia (AML)." | 3.85 | Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis. ( Al Omar, S; Al Qasem, W; Anabtawi, N; Rihani, R, 2017) |
| "In this retrospective study, we analyzed the clinical data and outcome of patients with AML who did or did not receive prophylactic ciprofloxacin 500 mg BD for neutropenic fever." | 3.83 | Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy. ( Foratyazdi, M; Ghadiany, M; Mehdizadeh, M; Mohammad Alizadeh, A; Rahimi, H; Rezvani, H; Zamani, N, 2016) |
| "Fifty consecutive episodes of neutropenia were studied in patients with AML who received prophylaxis with ciprofloxacin and these were compared with a historic control group of another 50 consecutive episodes of neutropenia in AML patients who did not receive antibiotic prophylaxis." | 3.69 | [Prophylaxis with ciprofloxacin in postchemotherapy neutropenia in acute myeloid leukemia]. ( Bueno, J; Juliá, A; López, A; Novo, A; Soler, JA, 1994) |
| "Twenty-four episodes of fever in neutropenic patients with haematological malignancy were treated with ciprofloxacin." | 3.67 | Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients. ( Farrell, ID; Geddes, AM; Leyland, MJ; Smith, GM, 1986) |
| "Bacterial infections are common during induction therapy in children and adolescents with acute leukaemia and may cause infection-related mortality." | 3.01 | Comparative effectiveness and safety of antibiotic prophylaxis during induction chemotherapy in children with acute leukaemia: a systematic review and meta-analysis. ( Cheng, G; Diao, S; Jia, Z; Lu, X; Luo, J; Xin, L; Yang, M; Zeng, L; Zhang, L, 2023) |
| "Treatment with voriconazole was promptly started with success." | 1.43 | Acute isolated appendicitis due to Aspergillus carneus in a neutropenic child with acute myeloid leukemia. ( Bergami, E; Cavanna, C; Decembrino, N; Introzzi, F; Lallitto, F; Mangione, F; Marone, P; Tamarozzi, F; Tortorano, AM; Zecca, M, 2016) |
| "Intensifying treatment for pediatric acute myeloid leukemia (AML) has improved survival, with infections now being a leading cause of morbidity." | 1.42 | Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia. ( Felsenstein, S; Fu, C; Hoffman, JA; Orgel, E; Rushing, T, 2015) |
| "Intensive chemotherapy for pediatric acute myeloid leukemia incurs the risk of infectious complications, but the benefits of antibiotic prophylaxis remain unclear." | 1.40 | Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia. ( Avutu, V; Cao, X; Flynn, PM; Gaur, AH; Hayden, RT; Howard, SC; Inaba, H; Marszal, LN; Pounds, SB; Pui, CH; Ribeiro, RC; Rubnitz, JE, 2014) |
| "Treatment with ciprofloxacin and gamma-globulin dramatically improved the patient's clinical features." | 1.32 | [Pseudomonas sepsis with ecthyma gangrenosum in an acute myeloid leukemia patient]. ( Komatsu, N; Mori, M; Nagai, T; Obara, Y; Ohmine, K; Ozawa, K; Toshima, M, 2004) |
| "Penicillin G prophylaxis was associated with an increased incidence of fever of unknown origin and more frequent isolation of aerobic gram-negative bacteria in surveillance cultures." | 1.29 | Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy. ( de Jong, M; de Jong, P; Kuijper, E; van der Lelie, J, 1993) |
| "In ciprofloxacin-treated patients the flora were almost completely ciprofloxacin-resistant, whereas in the control groups resistant flora were detected only occasionally." | 1.28 | Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. ( Huovinen, P; Kotilainen, P; Nikoskelainen, J, 1990) |
| " The mean serum ciprofloxacin concentrations, measured 1, 2, 3 and 4 h after dosage were reduced for up to ten days after the start of chemotherapy." | 1.28 | Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy. ( Johnson, EJ; MacGowan, AP; Potter, MN; Reeves, DS; Slade, RR; Stockley, RJ; White, LO, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.78) | 18.7374 |
| 1990's | 9 (25.00) | 18.2507 |
| 2000's | 6 (16.67) | 29.6817 |
| 2010's | 15 (41.67) | 24.3611 |
| 2020's | 5 (13.89) | 2.80 |
| Authors | Studies |
|---|---|
| Yeh, TC | 2 |
| Hou, JY | 2 |
| Huang, TH | 2 |
| Lu, CH | 1 |
| Sun, FJ | 1 |
| Huang, HM | 1 |
| Liu, HC | 2 |
| Yang, M | 1 |
| Lu, X | 1 |
| Xin, L | 1 |
| Luo, J | 1 |
| Diao, S | 1 |
| Jia, Z | 1 |
| Cheng, G | 1 |
| Zeng, L | 1 |
| Zhang, L | 1 |
| Kaya, Z | 1 |
| Alıcı, N | 1 |
| Kırkız, S | 1 |
| Koçak, Ü | 1 |
| Moreno, AF | 1 |
| Lavín-Alconero, L | 1 |
| de Ugarriza, PL | 1 |
| Blanco, LS | 1 |
| Hernández, SC | 1 |
| Burgués, JMB | 1 |
| de Miguel, MI | 1 |
| Huerta, AJG | 1 |
| Zarzuela, MP | 1 |
| Boluda, B | 1 |
| Humala, K | 1 |
| Calabuig, ML | 1 |
| Amigo, ML | 1 |
| Casas, MC | 1 |
| Del Mar García-Saiz, M | 1 |
| Verdugo, AF | 1 |
| Domínguez, JF | 1 |
| Bernal, T | 2 |
| Valéry, M | 1 |
| Bourrel, AS | 1 |
| Grignano, E | 1 |
| Kernéis, S | 1 |
| Contejean, A | 1 |
| Przybylski, DJ | 1 |
| Reeves, DJ | 1 |
| Lorenzana, N | 1 |
| Avila, LF | 1 |
| Alonso, S | 1 |
| Colado, E | 1 |
| Magréault, S | 1 |
| Leroux, S | 1 |
| Touati, J | 1 |
| Storme, T | 1 |
| Jacqz-Aigrain, E | 1 |
| Gupta, NK | 1 |
| Masia, R | 1 |
| De Rosa, FG | 1 |
| Motta, I | 1 |
| Audisio, E | 1 |
| Frairia, C | 1 |
| Busca, A | 1 |
| Di Perri, G | 1 |
| Marmont, F | 1 |
| Ghadiany, M | 1 |
| Rahimi, H | 1 |
| Rezvani, H | 1 |
| Mohammad Alizadeh, A | 1 |
| Zamani, N | 1 |
| Mehdizadeh, M | 1 |
| Foratyazdi, M | 1 |
| Chen, KH | 1 |
| Chang, CY | 1 |
| Liang, DC | 1 |
| Inaba, H | 1 |
| Gaur, AH | 1 |
| Cao, X | 1 |
| Flynn, PM | 1 |
| Pounds, SB | 1 |
| Avutu, V | 1 |
| Marszal, LN | 1 |
| Howard, SC | 1 |
| Pui, CH | 1 |
| Ribeiro, RC | 1 |
| Hayden, RT | 1 |
| Rubnitz, JE | 1 |
| Mayer, K | 1 |
| Hahn-Ast, C | 1 |
| Mückter, S | 1 |
| Schmitz, A | 1 |
| Krause, S | 1 |
| Felder, L | 1 |
| Bekeredjian-Ding, I | 1 |
| Molitor, E | 1 |
| Brossart, P | 1 |
| von Lilienfeld-Toal, M | 1 |
| Felsenstein, S | 1 |
| Orgel, E | 1 |
| Rushing, T | 1 |
| Fu, C | 1 |
| Hoffman, JA | 1 |
| Decembrino, N | 1 |
| Zecca, M | 1 |
| Tortorano, AM | 1 |
| Mangione, F | 1 |
| Lallitto, F | 1 |
| Introzzi, F | 1 |
| Bergami, E | 1 |
| Marone, P | 1 |
| Tamarozzi, F | 1 |
| Cavanna, C | 1 |
| Pohlen, M | 1 |
| Marx, J | 1 |
| Mellmann, A | 1 |
| Becker, K | 1 |
| Mesters, RM | 1 |
| Mikesch, JH | 1 |
| Schliemann, C | 1 |
| Lenz, G | 1 |
| Müller-Tidow, C | 1 |
| Büchner, T | 1 |
| Krug, U | 1 |
| Stelljes, M | 1 |
| Karch, H | 1 |
| Peters, G | 1 |
| Gerth, HU | 1 |
| Görlich, D | 1 |
| Berdel, WE | 1 |
| Baluch, A | 1 |
| Pasikhova, Y | 1 |
| Snyder, M | 1 |
| Al Omar, S | 1 |
| Anabtawi, N | 1 |
| Al Qasem, W | 1 |
| Rihani, R | 1 |
| Erikci, AA | 1 |
| Ozturk, A | 1 |
| Karagoz, B | 1 |
| Bilgi, O | 1 |
| Turken, O | 1 |
| Top, C | 1 |
| Kandemir, EG | 1 |
| Bousquet, A | 1 |
| Demoures, T | 1 |
| Malfuson, JV | 1 |
| Martinaud, C | 1 |
| Soler, C | 1 |
| Smith, RE | 1 |
| Bryant, J | 1 |
| DeCillis, A | 1 |
| Anderson, S | 1 |
| Obara, Y | 1 |
| Nagai, T | 1 |
| Mori, M | 1 |
| Ohmine, K | 1 |
| Toshima, M | 1 |
| Komatsu, N | 1 |
| Ozawa, K | 1 |
| Di Cataldo, A | 1 |
| La Spina, M | 1 |
| Bertuna, G | 1 |
| Lo Nigro, L | 1 |
| Branciforte, F | 1 |
| Castagnola, E | 1 |
| López, A | 1 |
| Soler, JA | 1 |
| Juliá, A | 1 |
| Novo, A | 1 |
| Bueno, J | 1 |
| de Jong, P | 1 |
| de Jong, M | 1 |
| Kuijper, E | 1 |
| van der Lelie, J | 1 |
| Bloch, KC | 1 |
| Nadarajah, R | 1 |
| Jacobs, R | 1 |
| Carlens, S | 1 |
| Ringdén, O | 1 |
| Aschan, J | 1 |
| Hägglund, H | 1 |
| Ljungman, P | 1 |
| Mattsson, J | 1 |
| Remberger, M | 1 |
| Naughton, M | 1 |
| Brown, R | 1 |
| Adkins, D | 1 |
| DiPersio, J | 1 |
| Persson, L | 1 |
| Vikerfors, T | 1 |
| Sjöberg, L | 1 |
| Engervall, P | 1 |
| Tidefelt, U | 1 |
| Lee, DG | 1 |
| Choi, SM | 1 |
| Choi, JH | 1 |
| Yoo, JH | 1 |
| Park, YH | 1 |
| Kim, YJ | 1 |
| Lee, S | 1 |
| Min, CK | 1 |
| Kim, HJ | 1 |
| Kim, DW | 1 |
| Lee, JW | 1 |
| Min, WS | 1 |
| Shin, WS | 1 |
| Kim, CC | 1 |
| Donnelly, JP | 1 |
| Maschmeyer, G | 1 |
| Daenen, S | 1 |
| Moriuchi, Y | 1 |
| Kamihira, S | 1 |
| Yamamura, M | 1 |
| Mori, H | 1 |
| Miyazaki, Y | 1 |
| Tokunaga, S | 1 |
| Nonaka, H | 1 |
| Amagasaki, T | 1 |
| Yamada, Y | 1 |
| Yoshida, Y | 1 |
| Kotilainen, P | 1 |
| Nikoskelainen, J | 1 |
| Huovinen, P | 1 |
| Johnson, EJ | 1 |
| MacGowan, AP | 1 |
| Potter, MN | 1 |
| Stockley, RJ | 1 |
| White, LO | 1 |
| Slade, RR | 1 |
| Reeves, DS | 1 |
| Smith, GM | 1 |
| Leyland, MJ | 1 |
| Farrell, ID | 1 |
| Geddes, AM | 1 |
2 reviews available for ciprofloxacin and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Comparative effectiveness and safety of antibiotic prophylaxis during induction chemotherapy in children with acute leukaemia: a systematic review and meta-analysis.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Chil | 2023 |
Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Breast Neoplasms; Ciprofloxacin; Dr | 1997 |
4 trials available for ciprofloxacin and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients-efficacy and microbiologic safety.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Febrile Neutropenia; Fosfomycin; Hematopoietic Stem Cell Trans | 2023 |
Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.
Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Ciprofloxacin; Drug Ther | 2002 |
Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Ciprofloxacin; Colistin; Drug Therap | 1992 |
[Comparison of ciprofloxacin with polymyxin B for infection prophylaxis in neutropenic patients with acute non-lymphocytic leukemia].
Topics: Administration, Inhalation; Administration, Oral; Bacterial Infections; Ciprofloxacin; Drug Administ | 1990 |
30 other studies available for ciprofloxacin and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacteremia; Child; Ciprofloxacin; | 2021 |
Identifying Risk Factors and Improving Preventive Strategies for Febrile Neutropenia in Children with Leukemia Receiving Ciprofloxacin Prophylaxis
Topics: Child; Ciprofloxacin; Febrile Neutropenia; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphobl | 2023 |
Successful conservative treatment of necrotizing fasciitis associated with Aeromonas veronii in a patient with acute myeloid leukemia.
Topics: Aeromonas veronii; Aged; Anti-Bacterial Agents; Cefepime; Ciprofloxacin; Combined Modality Therapy; | 2020 |
Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Clostridioides difficile; | 2017 |
The impact of antimicrobial prophylaxis in morbidity and infections during azacitidine treatment.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Antimetabolites, Antineo | 2017 |
UPLC/MS/MS assay for the simultaneous determination of seven antibiotics in human serum-Application to pediatric studies.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Blood Chemical Analysis; Calibration; | 2019 |
Cord colitis syndrome: a cause of granulomatous inflammation in the upper and lower gastrointestinal tract.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Colitis; Cord Blood Stem Cell Transplantation; Crohn Di | 2013 |
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.
Topics: Adult; Aged; Antibiotic Prophylaxis; Bacteremia; Bacteria; Bacterial Infections; Ciprofloxacin; Fema | 2013 |
Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy.
Topics: Adolescent; Aged; Antibiotic Prophylaxis; Ciprofloxacin; Female; Fever; Humans; Incidence; Induction | 2016 |
Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschoo | 2014 |
Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacteri | 2014 |
Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infecti | 2015 |
Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacteria; Child; Child, Presc | 2015 |
Acute isolated appendicitis due to Aspergillus carneus in a neutropenic child with acute myeloid leukemia.
Topics: Acute Disease; Acyclovir; Amphotericin B; Antifungal Agents; Appendicitis; Aspergillosis; Aspergillu | 2016 |
Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineopl | 2016 |
Successful management of Mycobacterium haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient.
Topics: Anti-Bacterial Agents; Biopsy; Cellulitis; Ciprofloxacin; Clarithromycin; Female; Graft vs Host Dise | 2017 |
Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Child; | 2017 |
Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Ciprofloxacin; Dexamethason | 2008 |
Campylobacter jejuni cutaneous infection in a patient with graft versus host disease.
Topics: Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Erysipelas; Graft vs Host Disease; He | 2012 |
Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cipr | 2003 |
[Pseudomonas sepsis with ecthyma gangrenosum in an acute myeloid leukemia patient].
Topics: Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Ciprofloxacin; Cytarabine; Ec | 2004 |
Spleen and lung involvement by Acinetobacter calcoaceticus bacteremia mimicking deep fungal infection in a child with acute non-lymphoblastic leukemia.
Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Infective Agents; Bacterial Typing Techn | 2006 |
[Prophylaxis with ciprofloxacin in postchemotherapy neutropenia in acute myeloid leukemia].
Topics: Adult; Aged; Bacterial Infections; Ciprofloxacin; Female; Humans; Leukemia, Myeloid, Acute; Male; Mi | 1994 |
Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Bacteremia; Ciprofloxacin; Humans; Leukemia, Myeloid, Acute; Mid | 1993 |
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Topics: Adult; Anti-Infective Agents; Bone Marrow Transplantation; Ciprofloxacin; Cyclophosphamide; Disease- | 1998 |
Tularemia--an unusual cause of a solitary pulmonary nodule in the post-transplant setting.
Topics: Anti-Infective Agents; Ciprofloxacin; Francisella tularensis; Hematopoietic Stem Cell Transplantatio | 1999 |
Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; | 2000 |
Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin.
Topics: Aged; Ciprofloxacin; Coagulase; Drug Resistance, Microbial; Female; Humans; Immune Tolerance; Leukem | 1990 |
Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ciprofloxacin; Dr | 1990 |
Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients.
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Ciprofloxacin; Female; Fever; Half-Life; Humans; | 1986 |